Considerations For Using Established Versus Novel Endpoints In Decentralized Trials

 
• By Vibha Sharma

UK and US regulators explained why some established clinical endpoints are not suitable for use in decentralized trials, and discussed principles to guide the development of novel digital endpoints.

WOMAN TELEHEALTH PATIENT
Decentralized trials use technologies to collect clinical data remotely • Source: Alamy

More from Clinical Trials

More from R&D